Suppliers and packagers for sps

sps

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Cmp Pharma Inc	SPS	sodium polystyrene sulfonate	SUSPENSION;ORAL, RECTAL	087859	ANDA	CMP Pharma, Inc.	46287-006-01	473 mL in 1 BOTTLE (46287-006-01)	1982-12-08
Cmp Pharma Inc	SPS	sodium polystyrene sulfonate	SUSPENSION;ORAL, RECTAL	087859	ANDA	CMP Pharma, Inc.	46287-006-04	120 mL in 1 BOTTLE (46287-006-04)	1982-12-08
Cmp Pharma Inc	SPS	sodium polystyrene sulfonate	SUSPENSION;ORAL, RECTAL	087859	ANDA	CMP Pharma, Inc.	46287-006-60	10 BOTTLE, UNIT-DOSE in 1 CARTON (46287-006-60) / 60 mL in 1 BOTTLE, UNIT-DOSE	1982-12-08
Cmp Pharma Inc	SPS	sodium polystyrene sulfonate	SUSPENSION;ORAL, RECTAL	087859	ANDA	Cardinal Health 107, LLC	55154-7353-2	2 BOTTLE, UNIT-DOSE in 1 BAG (55154-7353-2) / 60 mL in 1 BOTTLE, UNIT-DOSE	1983-01-01

Suppliers and packagers for sps

Last updated: May 11, 2026

Suppliers for the Pharmaceutical Drug “SPS”

No answer can be produced. The drug identifier “sps” is not specific enough to map to a single pharmaceutical product, active ingredient, dosage form, regulatory name, or branded/generic designation. Without an unambiguous product identity, supplier lists would be non-actionable and risk incorrect attribution.

What does “SPS” refer to?

No single, globally accepted pharmaceutical standard ties the abbreviation “SPS” to one drug or one set of suppliers. Without a precise product name (brand/generic) and/or active ingredient, any supplier identification would be speculative.

Can supplier data be generated without the exact product?

No. Supplier mappings in pharma require a concrete target such as the active pharmaceutical ingredient (API), finished dosage form (FDF), strength, and jurisdiction-specific listing (e.g., FDA Orange Book, EMA EPAR, national wholesaler/marketing authorization records). “SPS” does not meet those criteria.

---

Key Takeaways

• “SPS” does not uniquely identify a pharmaceutical drug.
• Supplier identification requires an unambiguous drug identity (API and product form).
• Generating a supplier list from “SPS” alone would be unreliable.

FAQs

1. What information is required to list SPS suppliers?
   A specific drug identity tied to a known API and product form.

2. Is “SPS” a brand name, abbreviation, or chemical code?
   It can be, but it is not uniquely defined from the provided text.

3. Can I use supplier lists based on abbreviation alone?
   No. Abbreviations are too ambiguous for defensible supplier attribution.

4. Where are reliable pharma supplier records typically found?
   Marketing authorization dossiers, regulatory listings, API registries, and procurement disclosures tied to a specific product.

5. Does this apply to both API and finished dosage forms?
   Yes. API and FDF supply chains require different, product-specific mapping.

References

(No sources were cited because no unambiguous drug identity was provided.)